RestorGenex Appoints Mark Weinberg, MD, MBA Senior Vice President Of Clinical Development
8/4/2014 9:57:48 AM
RestorGenex Corporation (OTCQB: RESX), a specialty biopharmaceutical company initially focused on developing products for dermatology, ophthalmology and women’s health, announced today the appointment of Mark Weinberg MD, MBA as Senior Vice President of Clinical Development.
Before joining RestorGenex, Dr. Weinberg served as Vice President, Global Clinical Science at Astellas Pharma Global Development.
Help employers find you! Check out all the jobs and post your resume.
comments powered by